PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO
Autor: | Aguirre, A, García, E, Bierschwale, H, Arce, CA |
---|---|
Zdroj: | In Value in Health 2009 12(7):A522-A523 |
Databáze: | ScienceDirect |
Externí odkaz: |